Skip to content
PromotEdge International

Home Guides Life science marketing strategy

Guides · Guide

Life science marketing strategy for B2B suppliers

Suppliers to pharmaceutical, biotech and diagnostics companies sell to people who check everything: a scientist who needs the material to perform, a quality team that needs it documented, a regulatory team that needs it filed, and procurement that needs a second source. Marketing that works for them is precise, technical and careful with regulatory words. This guide sets out a life science marketing strategy for B2B suppliers, from positioning to measurement, with the claims rules that matter most. It is general information, not legal or regulatory advice. It sits under our main guide to CDMO marketing strategy.

Reviewed by Milan ShyamalUpdated 12 Nov 20263 min read

The short answer

What is a life science marketing strategy?

A life science marketing strategy is the plan a B2B supplier uses to reach scientists, quality and regulatory teams and procurement at pharmaceutical, biotech and diagnostics companies. It rests on precise positioning, technical content written with your own scientists, search and LinkedIn aimed at named roles, and regulatory claims kept exact: an FDA registration is never an approval, and GMP claims need proof.

Key takeaways
  • Life science buyers are committees: scientists, quality, regulatory and procurement each check different things.
  • Technical content by your own named scientists earns more trust than any slogan.
  • Never say or imply FDA approval because of a registration; FDA calls that misleading.
  • State GMP status, inspections and certifications only with dates and proof.
  • Measure qualified inquiries, samples, audits and supply agreements.

Need this done for your business? A person reads every message and replies.

Ask for a call back

Life science buyers and what to give each

The members of a life science buying committee, what each checks, and the content that answers them.

PromotEdge International planning table; regulatory wording from 21 CFR 207.77, read 12 November 2026.
BuyerWhat they checkContent that answers
ScientistsPerformance in their processApplication notes, methods, data
Quality assuranceConsistency and documentationCertificates, audit access, change control
Regulatory affairsFiling support in each marketRegulatory support files and status, dated
ProcurementSupply security and priceCapacity, lead times, second site

Define the buyer committee and what each member checks, position on a specific capability, publish technical content by named scientists, build pages for the searches scientists and quality teams make, reach named roles on LinkedIn, and keep every regulatory claim exact. Measure qualified inquiries, samples, audits and agreements.

Registration is not approval; GMP and inspection claims need proof and dates.

Know the buying committee

A life science purchase is rarely one person's call. Map who decides and what each checks:

  • Scientists and process developers: does it perform in their process? They want data, methods and application notes.
  • Quality assurance: is it made and documented consistently? They want certificates, audit access and change control.
  • Regulatory affairs: can it be filed? They want regulatory support files and status in each market.
  • Procurement and supply chain: is supply secure and the price fair? They want capacity, lead times and a second site.

Position on a specific capability

Life science buyers ignore broad claims. Position on something specific and checkable: a technology, a scale, a class of molecule, a speed of tech transfer, a regulatory track record in named markets. Write it in the buyer's words and test it with your own scientists and customers before it goes on the website.

Technical content by named scientists

Scientists trust scientists. Publish application notes, method papers, case studies with consent and plain explanations of your process, written or reviewed by named members of your team. In CMI's 2027 B2B research, marketers named useful, practical information (64%), industry expertise (59%) and customer stories (50%) as top ways to build trust. Google's helpful content guidance asks the same: clear authorship and first-hand expertise. Our content marketing service writes this with your scientists.

Search and AI answers

Scientists search for specific problems, techniques and materials, and increasingly read AI summaries first: Pew Research Center found users clicked a result link on 8% of visits with an AI summary against 15% without. Build pages for each capability, application and material, with a clear answer at the top, named authors and sources, so they are found and cited. Our B2B SEO service builds them; our life science SEO guide goes deeper.

LinkedIn and email

LinkedIn's ad targeting reaches members by job title, company, industry and seniority, so a campaign can reach process development, quality and procurement roles at named companies. Lead with a technical asset, not a sales pitch. Follow up with consented email: in the USA, the FTC's CAN-SPAM guide applies; in Canada, CASL requires consent first.

Regulatory claims: exact words only

FDA's rule on registration, 21 CFR 207.77, says registering an establishment or listing a drug does not denote approval, and that any representation creating an impression of official approval because of registration, listing, an NDC or a registration number is misleading and constitutes misbranding. So never write "FDA-approved facility". State an FDA inspection, a GMP status under 21 CFR parts 210 and 211, or a certification only if it is true, with the date and, where you can, the document. Make no therapeutic claims for a customer's product.

How to measure life science marketing

Count qualified inquiries by source, samples and trial orders, quality audits requested and passed, regulatory support files requested, and supply agreements signed, with the time from first inquiry to each. Website visits and followers are context.

What we do and do not do

PromotEdge International is an international strategy, technology, marketing and design company, and our delivery team is in India. We plan life science marketing, write technical content with your team, and build websites, search and campaigns. We give no regulatory or legal advice; your regulatory team approves every claim. Life science clients we have worked for include Kopran and Novozymes. That work was for their business in India and was delivered by our team there. Our life science marketing service page describes the work.

Facts we rely on: see our company facts for what we state about ourselves and where each fact comes from.

Common questions

  • Map the buying committee (scientists, quality, regulatory, procurement) and what each checks, position on a specific capability, publish technical content by named scientists, build search pages for the problems they search, reach named roles on LinkedIn, and keep every regulatory claim exact and dated.

  • No. FDA's rule at 21 CFR 207.77 says registration or listing does not denote approval, and that any representation creating an impression of official approval because of registration, listing, an NDC or a registration number is misleading and constitutes misbranding.

  • Only if it is true, with specifics: which site, which standard, what inspection or certification and its date, and the document where you can share it. Quality teams check these claims, and a vague one costs more trust than it earns.

  • Application notes, method papers, case studies with customer consent, process explanations, and clear regulatory and quality pages, written or reviewed by named scientists. CMI's research finds useful, practical information and industry expertise are top ways B2B marketers build trust.

  • By qualified inquiries, samples and trial orders, quality audits requested and passed, regulatory support files requested, and supply agreements signed, with the time from first inquiry to each. Visits and followers are context.

  • No. We plan life science marketing, write technical content with your team, and build websites, search and campaigns. We give no regulatory or legal advice, and your regulatory team approves every claim we publish.

Brands we have worked with

  • Fine Organics
  • Weichai
  • Novozymes
  • Dozco
  • SANY
  • Prezent
  • Honest AI
  • SCENNE
  • Sara International
  • Vega MPS
  • Desi Machine Pvt. Ltd.

Work delivered from India. Results are shared one to one, under NDA.

See all clients

Talk to us

Tell us what you need

We use these details only to reply to you.

Phone or WhatsApp (optional)
Who is it for? (optional)

Rather talk now?

How we work

  1. 01

    Tell us the goal

    A rough note through the form on what you sell and what needs to change.

  2. 02

    We study your market

    How people find you today, where inquiries get lost, then a call in your working day.

  3. 03

    A written plan

    The work, who does it and how it is measured. Nothing starts until you approve it.

  4. 04

    The work starts

    Our team in India does the work, with calls set in your working hours.

  5. 05

    Reports and visits

    Every number we report shows its source and date range, and we travel to our clients every 3 to 4 months.

Chat with us